Meanwhile, the stronger capability to secrete PRF and TNF-α rather than GZMB through MHC class II molecules might be responsible for the anti-tumor activity of CD8+PD-1+CD161+ T cells. This evidence concerns the gene KLRB1 and neoplasm.